FR2119015B1 - - Google Patents

Info

Publication number
FR2119015B1
FR2119015B1 FR7146183A FR7146183A FR2119015B1 FR 2119015 B1 FR2119015 B1 FR 2119015B1 FR 7146183 A FR7146183 A FR 7146183A FR 7146183 A FR7146183 A FR 7146183A FR 2119015 B1 FR2119015 B1 FR 2119015B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7146183A
Other languages
French (fr)
Other versions
FR2119015A1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JA
Original Assignee
JA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP11704870A external-priority patent/JPS4920790B1/ja
Priority claimed from JP12828170A external-priority patent/JPS4921151B1/ja
Priority claimed from JP12714470A external-priority patent/JPS4921150B1/ja
Application filed by JA filed Critical JA
Publication of FR2119015A1 publication Critical patent/FR2119015A1/fr
Application granted granted Critical
Publication of FR2119015B1 publication Critical patent/FR2119015B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
FR7146183A 1970-12-22 1971-12-22 Expired FR2119015B1 (enExample)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11704870A JPS4920790B1 (enExample) 1970-12-22 1970-12-22
JP12828170A JPS4921151B1 (enExample) 1970-12-25 1970-12-25
JP12714470A JPS4921150B1 (enExample) 1970-12-28 1970-12-28

Publications (2)

Publication Number Publication Date
FR2119015A1 FR2119015A1 (enExample) 1972-08-04
FR2119015B1 true FR2119015B1 (enExample) 1975-03-14

Family

ID=27313291

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7146183A Expired FR2119015B1 (enExample) 1970-12-22 1971-12-22

Country Status (3)

Country Link
US (1) US3770729A (enExample)
DE (1) DE2163657A1 (enExample)
FR (1) FR2119015B1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4315011A (en) * 1978-07-12 1982-02-09 Richter Gedeon Vegyeszeti Gyar Rt. 1-Alkyl-9-bromohexahydroindolo quinolizium salts and use thereof to increase blood flow
US6323206B1 (en) 1996-07-12 2001-11-27 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
EP0920306A2 (en) 1996-07-12 1999-06-09 Leukosite, Inc. Chemokine receptor antagonists and methods of use therefor
US6509346B2 (en) 1998-01-21 2003-01-21 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
CA2318088A1 (en) 1998-01-21 1999-07-29 Yoshisuke Nakasato Chemokine receptor antagonists and methods of use therefor
WO1999037651A1 (en) 1998-01-21 1999-07-29 Millenium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6613905B1 (en) 1998-01-21 2003-09-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6503926B2 (en) 1998-09-04 2003-01-07 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6288083B1 (en) 1998-09-04 2001-09-11 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US7271176B2 (en) * 1998-09-04 2007-09-18 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use thereof
US7541365B2 (en) * 2001-11-21 2009-06-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
TWI291467B (en) 2002-11-13 2007-12-21 Millennium Pharm Inc CCR1 antagonists and methods of use therefor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1251331B (de) * 1965-01-07 1967-10-05 Farbenfabriken Bayer Aktiengesellschaft, Leverkusen Verfahren zur Herstellung von basisch substituierten 6,11 Dihydro dibenzo [b e]-oxepm 6 onen

Also Published As

Publication number Publication date
US3770729A (en) 1973-11-06
FR2119015A1 (enExample) 1972-08-04
AU3712771A (en) 1973-06-28
DE2163657A1 (de) 1972-07-13

Similar Documents

Publication Publication Date Title
ATA96471A (enExample)
AU1146470A (enExample)
AU2044470A (enExample)
AU1473870A (enExample)
AU1326870A (enExample)
AU2130570A (enExample)
AU2085370A (enExample)
AU2017870A (enExample)
AU1833270A (enExample)
AU1716970A (enExample)
AU1517670A (enExample)
AU1336970A (enExample)
AU1591370A (enExample)
AU1064870A (enExample)
AU2144270A (enExample)
AU2131570A (enExample)
AU2130770A (enExample)
AU1328670A (enExample)
AU1277070A (enExample)
AU1343870A (enExample)
AU1247570A (enExample)
ATA672271A (enExample)
AU2119370A (enExample)
AU1581370A (enExample)
AU1235770A (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse